B. Braun Lactated Ringer's Injection recalled for particulate matter contamination — product photo from the FDA
Serious riskFDA announcements

B. Braun Lactated Ringer's Injection recalled for particulate matter contamination

B. Braun Medical is recalling two lots of Lactated Ringer's Injection (1L, product code E7500) because the solution contains unwanted particles, including cellulose and stearates. If these particles enter a patient's bloodstream during use, they could cause serious complications including blood clots, tissue damage, or organ failure.

From the FDA notice · Read the official notice ↗ · All B. Braun recalls

What to do

  1. Stop using affected lots J4P756 and J4S843 immediately
  2. Contact B. Braun's Recalls Department at 844-903-6417 or recalls@bbraunusa.com to arrange return
  3. Healthcare providers should check stock and replace with non-recalled product
  4. Report any adverse events to FDA MedWatch at www.fda.gov/medwatch or 1-800-332-1088

Is yours affected?

Compare your label or packaging with the recalled product.

Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Illnesses reported
None reported

In the FDA's words

For Immediate Release - BETHLEHEM, PA – APRIL 28, 2026 – B. Braun Medical Inc. is voluntarily recalling two lots of Lactated Ringer’s Injection, E7500, 1L, to the hospital/healthcare facility level. The product has been found to have particulate matter in solution.

B. Braun has identified through complaints the potential for the product to contain particulate matter in solution. In the complaint investigations the particles were identified as cellulose and stearates with extremely low levels of inorganic materials such as copper. To date, B. Braun has not received any reports of adverse events related to this recall to date. If the particulate matter is observed before use, a minor delay could occur while obtaining a replacement product. If the particulate matter is loose and the container is used on a patient, there is a potential for the particulate to be infused into the circulatory system. This could lead to patient harm that may require additional medical intervention and/or lead to permanent impairment or death.

This product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting). Systemically, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis (breakdown of blood cells).

Read the full announcement

The solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Lactated Ringer's Injection USP is supplied sterile and nonpyrogenic in plastic containers packaged 12 per case.

Product Catalog Number

NDC Number

Product Description

Lot Number

Distribution Range

Expiration Date

Region Distributed

E7500

0264-7750-07

LAC RNG INJ 1L E3

J4P756

15NOV2024 – 06MAR2025

31MAY2027

US

E7500

0264-7750-07

LAC RNG INJ 1L E3

J4S843

13JAN2025 – 15MAY2025

31MAY2027

US

The product can be identified by product code E7500 or NDC 0264-7750-07. Product was distributed Nationwide to distributors, hospital, and healthcare facilities.

B. Braun is notifying its distributors and customers by mail and is arranging for return of all recalled products. Consumers and distributors that have product which is being recalled should stop using and arrange for return of the product using the Urgent Pharmaceutical Recall Acknowledgement form provided by the company.

Consumers with questions regarding this recall can contact B. Braun’s Recalls Department at 844-903-6417 or recalls@bbraunusa.com , Monday to Friday from 8:00 am to 5:00 pm EST.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online : www.fda.gov/medwatch/report.htm 1

Regular Mail or Fax : Download form www.fda.gov/MedWatch/getforms.htm 2 or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company Contact Information

Consumers:

B. Braun’s Recalls Department

844-903-6417

recalls@bbraunusa.com

Product Photos

Content current as of:

04/28/2026

Regulated Product(s)

Drugs

Follow FDA

Follow @US_FDA on X

Follow FDA on Facebook

Follow @FDArecalls on X

Recent Recalled Product Photos on FDA's Flickr Photostream

Related topics

ParticulateDrugsSold nationwideMore from FDA announcements